Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
MORGAN STANLEY TXG 10x Genomics, Inc. 13G/A 3.5% 2y
VANGUARD GROUP INC MURA Mural Oncology plc Ordinary Shares 13G 11.17% 2y
VANGUARD GROUP INC CRI Carters Inc 13G/A 10.04% 2y
NEUBERGER BERMAN GROUP LLC XPEL XPEL, Inc. 13G/A 0% 2y
MORGAN STANLEY GLOB Globant S.A. 13G/A 3.4% 2y
VANGUARD GROUP INC RMAX RE/MAX Holdings, Inc. 13G/A 5.48% 2y
VANGUARD GROUP INC DG Dollar General Corp 13G/A 10.03% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IIF Morgan Stanley India Investment Fund, Inc. 13G/A 10.3% 2y
MORGAN STANLEY AMRN Amarin Corp Plcuk 13G/A 1.6% 2y
VANGUARD GROUP INC QCOM Qualcomm Inc 13G/A 10.02% 2y
MORGAN STANLEY MELI Mercadolibre Inc 13G/A 3.9% 2y
GOLDMAN SACHS GROUP INC ALOR ALSP Orchid Acquisition Corporation I Class A Ordinary Share 13G/A 0% 2y
MORGAN STANLEY CHWY Chewy, Inc. 13G/A 4% 2y
VANGUARD GROUP INC KNF Knife River Corp 13G 10.76% 2y
Altai Capital Management, L.P. SKYH Sky Harbour Group Corp 13G 36.8% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD ASA ASA Gold & Precious Metals Ltd 13G/A 3.1% 2y
VANGUARD GROUP INC BG Bunge Global SA 13G 11.45% 2y
VANGUARD GROUP INC DD DuPont de Nemours, Inc. 13G/A 10.46% 2y
VANGUARD GROUP INC WSR Whitestone REIT 13G/A 11.16% 2y
VANGUARD GROUP INC INCY Incyte Corp 13G/A 10.02% 2y
VANGUARD GROUP INC PDCO Patterson Companies, Inc. 13G/A 10.02% 2y
VANGUARD GROUP INC HQY Healthequity, Inc. 13G/A 10.05% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC KAI Kadant Inc 13G 11.31% 2y
MORGAN STANLEY GHY PGIM Global High Yield Fund, Inc. 13G/A 8.3% 2y
VANGUARD GROUP INC NLOP Net Lease Office Properties 13G 10.08% 2y
MORGAN STANLEY FOLD AMICUS THERAPEUTICS, INC. 13G/A 4.2% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IHD Voya Emerging Markets High Dividend Equity Fund 13G/A 19.6% 2y
MORGAN STANLEY HEQ John Hancock Diversified Income Fund 13G/A 4.2% 2y
VANGUARD GROUP INC IDXX Idexx Laboratories Inc 13G/A 10.03% 2y
Saba Capital Management, L.P. DHF Bny Mellon High Yield Strategies Fund 13D 5.24% 2y
GLAZER CAPITAL, LLC HT Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest 13G/A 0% 2y
Growth Equity Opportunities Fund IV, LLC ADXN Addex Therapeutics Ltd. 13D/A 6.4% 2y
Aequanimitas Limited Partnership RANI Rani Therapeutics Holdings, Inc. 13D/A 0% 2y
South Cone Investments Limited Partnership RANI Rani Therapeutics Holdings, Inc. 13D/A 46.9% 2y
James A. Cacioppo JUSH Jushi Holdings Inc. 13D/A 17.95% 2y
Burgundy Asset Management Ltd. BRDG Bridge Investment Group Holdings Inc. 13G/A 4.02% 2y
Venrock Opportunities Fund, L.P. VRDN Viridian Therapeutics, Inc.\DE 13G 5.2% 2y
Kenneth S. Ansin EBTC Enterprise Bancorp Inc. 13D 9.8% 2y
Firment Shipping Inc. GLBS Globus Maritime Ltd 13D/A 19% 2y
Alex Chesterman CZOO Cazoo Group Ltd 13D/A 1.9% 2y
Mill Road Capital III, L.P. CULP Culp Inc 13D/A 5.5% 2y
GAMCO INVESTORS, INC. ET AL MOD Modine Manufacturing Co 13D/A 4.51% 2y
Hill Path Capital LP PLAY Dave & Buster's Entertainment, Inc. 13D/A 17.7% 2y
GIC Private Ltd YUMC Yum China Holdings, Inc. 13G 5.03% 2y
William P. Foley, II SST System1, Inc. 13G 5.9% 2y
Lind Global Fund II LP RNAZ Transcode Therapeutics, Inc. 13G 9.9% 2y
Theofilos Charles Steve ECOR electroCore, Inc. 13G 9.9% 2y
THOMPSON DAVIS & CO., INC. SOHON Sotherly Hotels Inc. 13D/A 4.34% 2y
Glory Achievement Fund Limited NIU Niu Technologies 13D 31.8% 2y
AdvisorShares Trust PW Power REIT 13G/A 3.81% 2y